Clinical Trials Logo

Behavior, Sex clinical trials

View clinical trials related to Behavior, Sex.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03685643 Completed - Adolescent Behavior Clinical Trials

Study Proposal for Web Based Intervention to Promote the Safe Usage of Dating Applications in Young Adults

Start date: September 7, 2018
Phase: N/A
Study type: Interventional

This study will evaluate the effectiveness of a program in promoting the safe usage of dating applications amongst young adults in Hong Kong. One group will receive the program regarding dating applications and the other group will receive a placebo program regarding health and exercise.

NCT ID: NCT03660709 Completed - Behavior, Sex Clinical Trials

Comparing the Efficacy of Enhanced and Standard HTC

Start date: September 1, 2018
Phase: N/A
Study type: Interventional

Objective The objectives of the study are to evaluate the relative efficacy of an enhanced version of HIV testing and counselling (EHTC) versus standard-of-care HIV testing and counselling (SHTC) in reducing sexual risk behaviours, increasing retesting rate and risk perception among men who have sex with men (MSM) in Hong Kong. Participants Inclusion criteria are: 1) men of age 18 years or above using HTC services at AIDS Concern, 2) anal intercourse with at least one man in the last six months, 3) able to read and comprehend Cantonese, 4) willingness to provide contact information and to complete a simple follow up evaluation at Month 6, and 5) no intention to leave Hong Kong for one month consecutively within the next six months. Those self-reported or tested to be HIV positive will be excluded from the study. Design A parallel-group and non-blinded randomized controlled trial (RCT) will be conducted. A total of 430 participants will be randomly allocated into the intervention group receiving EHTC (n=215) and the control group receiving SHTC (n=215). Evaluation will be performed six months afterwards. Outcomes Primary outcomes are: 1) Prevalence of unprotected anal intercourse with any and specific types of male partners during the 6-month follow up period; 2) uptake of any type of HIV antibody testing within the 6-month follow-up period, and 3) HIV risk perception.